Abdo WF, van de Warrenburg BP, Munneke M, van Geel WJ, Bloem BR, Kremer HP, et al. CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia. Neurology 2006; 67: 474-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Abe K, Hikita T, Yokoe M, Mihara M, Sakoda S. The "cross" signs in patients with multiple system atrophy: a quantitative study. J Neuroimaging 2006; 16: 73-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Apostolova LG, Klement I, Bronstein Y, Vinters HV, Cummings JL. Multiple system atrophy presenting with language impairment. Neurology 2006; 67: 726-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Armstrong RA, Cairns NJ, Lantos PL. Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes. Parkinsonism Relat Disord 2006; 12: 356-62. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Asahina M, Sato J, Tachibana M, Hattori T. Cerebral blood flow and oxygenation during head-up tilt in patients with multiple system atrophy and healthy control subjects. Parkinsonism Relat Disord 2006; 12: 472-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Ashour R, Jankovic J. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Mov Disord 2006; 21: 1856-63. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Baker KG, Huang Y, McCann H, Gai WP, Jensen PH, Halliday GM. P25alpha immunoreactive but alpha-synuclein immunonegative neuronal inclusions in multiple system atrophy. Acta Neuropathol 2006; 111: 193-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE. Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy. Brain 2006; 129: 2688-96. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE. Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease. Neurology 2006; 66: 378-83. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Berciano J, Boesch S, Perez-Ramos JM, Wenning GK. Olivopontocerebellar atrophy: toward a better nosological definition. Mov Disord 2006; 21: 1607-13. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Brenneis C, Boesch SM, Egger KE, Seppi K, Scherfler C, Schocke M, et al. Cortical atrophy in the cerebellar variant of multiple system atrophy: a voxel-based morphometry study. Mov Disord 2006; 21: 159-65. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Burk K, Daum I, Rub U. Cognitive function in multiple system atrophy of the cerebellar type. Mov Disord 2006; 21: 772-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Chaudhuri KR. Management of bladder dysfunction in patients with multiple-system atrophy. Nat Clin Pract Neurol 2006; 2: 652-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Deguchi K, Sasaki I, Ikeda K, Shimamura M, Urai Y, Tsukaguchi M, et al. The validity of a hyperventilation test for an investigation of autonomic failure: assessment in patients with multiple system atrophy and Parkinson's disease. Int J Clin Pract 2006; 60: 1542-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Diederich NJ, Goebel HH, Dooms G, Bumb A, Huber F, Kompoliti K, et al. Camptocormia associated with focal myositis in multiple-system atrophy. Mov Disord 2006; 21: 390-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi
El Fakhri G, Habert MO, Maksud P, Kas A, Malek Z, Kijewski MF, et al. Quantitative simultaneous (99m)Tc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging 2006; 33: 87-92. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Friess E, Kuempfel T, Modell S, Winkelmann J, Holsboer F, Ising M, et al. Paroxetine treatment improves motor symptoms in patients with multiple system atrophy. Parkinsonism Relat Disord 2006; 12: 432-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Geser F, Wenning GK, Seppi K, Stampfer-Kountchev M, Scherfler C, Sawires M, et al. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG). Mov Disord 2006; 21: 179-86. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Glass GA, Josephs KA, Ahlskog JE. Respiratory insufficiency as the primary presenting symptom of multiple-system atrophy. Arch Neurol 2006; 63: 978-81. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Gurevich T, Gur AY, Bornstein NM, Giladi N, Korczyn AD. Cerebral vasomotor reactivity in Parkinson's disease, multiple system atrophy and pure autonomic failure. J Neurol Sci 2006; 243: 57-60. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Hauser TK, Luft A, Skalej M, Nagele T, Kircher TT, Leube DT, et al. Visualization and quantification of disease progression in multiple system atrophy. Mov Disord 2006; 21: 1674-81. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Hofmann A, Tangri N, Lafontaine AL, Postuma RB. Myoclonus as an acute complication of low-dose hydromorphone in multiple system atrophy. J Neurol Neurosurg Psychiatry 2006; 77: 994-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Ito T, Sakakibara R, Yasuda K, Yamamoto T, Uchiyama T, Liu Z, et al. Incomplete emptying and urinary retention in multiple-system atrophy: when does it occur and how do we manage it? Mov Disord 2006; 21: 816-23. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Jellinger KA. P25alpha immunoreactivity in multiple system atrophy and Parkinson disease. Acta Neuropathol 2006; 112: 112. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Kokturk N, Gursel G, Kuruoglu R, Kervan F, Baysal AI. Multiple system atrophy presenting with acute respiratory failure due to diaphragmatic dysfunction. Tuberk Toraks 2006; 54: 370-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Konagaya M, Sakai M, Yoshida M, Hashizume Y. [An autopsy case of long-course multiple system atrophy (MSA) with remarkable atrophy and numerous NCI in the temporal lobe]. No To Shinkei 2006; 58: 430-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Krishnan S, Mathuranath PS, Sarma S, Kishore A. Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease. Neurol India 2006; 54: 268-72. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Lee PH, Lee G, Park HJ, Bang OY, Joo IS, Huh K. The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy. J Neural Transm 2006; 113: 1435-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Lee PH, Yeo SH, Kim HJ, Youm HY. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Mov Disord 2006; 21: 1975-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Mathias CJ. Multiple system atrophy and autonomic failure. J Neural Transm Suppl 2006: 343-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Muratori LM, Dapul G, Bartels MN, Gordon AM. Effect of object transport on grasp coordination in multiple system atrophy. Mov Disord 2006; 21: 555-63. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Nemoto H, Konno S, Nakazora H, Wakata N, Kurihara T. Pontine calcification in a case with cerebellar type of multiple system atrophy: incidental or related to synucleinopathy. Intern Med 2006; 45: 667-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Nesic N, Svetel M, Pekmezovic T, Ribaric K, Dragasevic N, Kostic V. [Clinical characteristics of multiple system atrophy in serbian population]. Vojnosanit Pregl 2006; 63: 861-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Ngai S, Tang YM, Du L, Stuckey S. Hyperintensity of the middle cerebellar peduncles on fluid-attenuated inversion recovery imaging: variation with age and implications for the diagnosis of multiple system atrophy. AJNR Am J Neuroradiol 2006; 27: 2146-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Nicoletti G, Fera F, Condino F, Auteri W, Gallo O, Pugliese P, et al. MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease. Radiology 2006; 239: 825-30. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Nonaka M, Imai T, Shintani T, Kawamata M, Chiba S, Matsumoto H. Non-invasive positive pressure ventilation for laryngeal contraction disorder during sleep in multiple system atrophy. J Neurol Sci 2006; 247: 53-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Oka H, Mochio S, Yoshioka M, Morita M, Onouchi K, Inoue K. Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy. Acta Neurol Scand 2006; 113: 221-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Ozawa T. Pathology and genetics of multiple system atrophy: an approach to determining genetic susceptibility spectrum. Acta Neuropathol 2006; 112: 531-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Ozawa T, Healy DG, Abou-Sleiman PM, Ahmadi KR, Quinn N, Lees AJ, et al. The alpha-synuclein gene in multiple system atrophy. J Neurol Neurosurg Psychiatry 2006; 77: 464-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Papp M, Kovacs T. [Multiple system atrophy: the beginning of a new era in the history of neurodegenerative diseases]. Ideggyogy Sz 2006; 59: 308-20. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 2006; 129: 1040-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Pavy-Le Traon A, Hughson RL, Thalamas C, Galitsky M, Fabre N, Rascol O, et al. Cerebral autoregulation is preserved in multiple system atrophy: A transcranial Doppler study. Mov Disord 2006; 21: 2122-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Pellecchia MT, Longo K, Pivonello R, Lucetti C, Marchese R, Spampani A, et al. Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test. Ann Neurol 2006; 60: 611-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Ripa S, Scaglione C, Rusconi LC. Transient left ventricular apical ballooning at the onset of multiple system atrophy. J Cardiovasc Med (Hagerstown) 2006; 7: 631-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Rouco I, Gomez JC, Lezcano E, Aniel-Quiroga MA, Velasco F, Barcena J, et al. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy]. Neurologia 2006; 21: 119-23. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Santens P, Vonck K, De Letter M, Van Driessche K, Sieben A, De Reuck J, et al. Deep brain stimulation of the internal pallidum in multiple system atrophy. Parkinsonism Relat Disord 2006; 12: 181-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Sartucci F, Orlandi G, Bonuccelli U, Borghetti D, Murri L, Orsini C, et al. Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson's disease. Neurol Sci 2006; 26: 395-401. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Schmitt I, Wullner U, Healy DG, Wood NW, Kolsch H, Heun R. The ADH1C stop mutation in multiple system atrophy patients and healthy probands in the United Kingdom and Germany. Mov Disord 2006; 21: 2034. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Schrag A, Geser F, Stampfer-Kountchev M, Seppi K, Sawires M, Kollensperger M, et al. Health-related quality of life in multiple system atrophy. Mov Disord 2006; 21: 809-15. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Seppi K, Hogl B, Diem A, Peralta C, Wenning GK, Poewe W. Levodopa-induced sleepiness in the Parkinson variant of multiple system atrophy. Mov Disord 2006; 21: 1281-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Seppi K, Peralta C, Diem-Zangerl A, Puschban Z, Mueller J, Poewe W, et al. Placebo-controlled trial of riluzole in multiple system atrophy. Eur J Neurol 2006; 13: 1146-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Seppi K, Schocke MF, Mair KJ, Esterhammer R, Scherfler C, Geser F, et al. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage 2006; 31: 240-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Seppi K, Schocke MF, Prennschuetz-Schuetzenau K, Mair KJ, Esterhammer R, Kremser C, et al. Topography of putaminal degeneration in multiple system atrophy: a diffusion magnetic resonance study. Mov Disord 2006; 21: 847-52. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Shiba K, Isono S. Tracheostomy abolishes paradoxical activation of the vocal cord adductor in multiple system atrophy. Auris Nasus Larynx 2006; 33: 295-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Shimohata T, Nakayama H, Shinoda H, Tsukada H, Takahashi S, Gejo F, et al. Multiple system atrophy with progressive nocturnal hypoxemia: case report with polysomnography and continuous positive airway pressure treatment. Eur Neurol 2006; 56: 258-60. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Shioda K, Nisijima K, Kato S. Electroconvulsive therapy for the treatment of multiple system atrophy with major depression. Gen Hosp Psychiatry 2006; 28: 81-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Shults CW, Barrett JM, Fontaine D. alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy. Neurosci Lett 2006; 405: 223-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Slawek J, Derejko M, Lass P, Dubaniewicz M. Camptocormia or Pisa syndrome in multiple system atrophy. Clin Neurol Neurosurg 2006; 108: 699-704. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Soma H, Yabe I, Takei A, Fujiki N, Yanagihara T, Sasaki H. Heredity in multiple system atrophy. J Neurol Sci 2006; 240: 107-10. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Talmant V, Esposito P, Stilhart B, Mohr M, Tranchant C. [Subthalamic stimulation in a patient with multiple system atrophy: a clinicopathological report]. Rev Neurol (Paris) 2006; 162: 363-70. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Tison F, Yekhlef F, Chrysostome V. Depression and self-reported depressive symptoms in multiple system atrophy compared to Parkinson's disease. Mov Disord 2006; 21: 1056-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Vogt IR, Lees AJ, Evert BO, Klockgether T, Bonin M, Wullner U. Transcriptional changes in multiple system atrophy and Parkinson's disease putamen. Exp Neurol 2006; 199: 465-78. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Wakabayashi K, Takahashi H. Cellular pathology in multiple system atrophy. Neuropathology 2006; 26: 338-45. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Young TM, Asahina M, Nicotra A, Mathias CJ. Skin vasomotor reflex responses in two contrasting groups of autonomic failure: multiple system atrophy and pure autonomic failure. J Neurol 2006; 253: 846-50. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Young TM, Asahina M, Watson L, Mathias CJ. Hemodynamic effects of clonidine in two contrasting models of autonomic failure: multiple system atrophy and pure autonomic failure. Mov Disord 2006; 21: 609-15. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Proceedings of the 2nd International Meeting on Multiple System Atrophy, June 17-18, 2004, Rome, Italy. J Neural Transm 2005; 112: 1601-704. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Armstrong RA, Lantos PL, Cairns NJ. Multiple system atrophy: laminar distribution of the pathological changes in frontal and temporal neocortex--a study in ten patients. Clin Neuropathol 2005; 24: 230-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Asahina M, Young TM, Bleasdale-Barr K, Mathias CJ. Differences in overshoot of blood pressure after head-up tilt in two groups with chronic autonomic failure: pure autonomic failure and multiple system atrophy. J Neurol 2005; 252: 72-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 2005; 11: 268-73. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Benrud-Larson LM, Sandroni P, Schrag A, Low PA. Depressive symptoms and life satisfaction in patients with multiple system atrophy. Mov Disord 2005; 20: 951-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Berciano J, Infante J, Garcia A, Polo JM, Volpini V, Combarros O. Very late-onset Friedreich's ataxia with minimal GAA1 expansion mimicking multiple system atrophy of cerebellar type. Mov Disord 2005; 20: 1643-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Berciano J, Wenning GK. The Lewis family revisited: no evidence for autosomal dominant multiple system atrophy. Parkinsonism Relat Disord 2005; 11: 363-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Biancalana V, Toft M, Le Ber I, Tison F, Scherrer E, Thibodeau S, et al. FMR1 premutations associated with fragile X-associated tremor/ataxia syndrome in multiple system atrophy. Arch Neurol 2005; 62: 962-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Bradbury J. Modelling of multiple system atrophy in mice. Lancet Neurol 2005; 4: 273. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Cilia R, Marotta G, Benti R, Pezzoli G, Antonini A. Brain SPECT imaging in multiple system atrophy. J Neural Transm 2005; 112: 1635-45. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Colosimo C, Tiple D, Wenning GK. Management of multiple system atrophy: state of the art. J Neural Transm 2005; 112: 1695-704. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Dalfo E, Ferrer I. Alpha-synuclein binding to rab3a in multiple system atrophy. Neurosci Lett 2005; 380: 170-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Diguet E, Fernagut PO, Scherfler C, Wenning G, Tison F. Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice. J Neural Transm 2005; 112: 613-31. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Duggal HS. Cognitive affective psychosis syndrome in a patient with sporadic olivopontocerebellar atrophy. J Neuropsychiatry Clin Neurosci 2005; 17: 260-2. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Factor SA, Qian J, Lava NS, Hubbard JD, Payami H. False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy. Ann Neurol 2005; 57: 462-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Fernagut PO, Ghorayeb I, Diguet E, Tison F. In vivo models of multiple system atrophy. Mov Disord 2005; 20 Suppl 12: S57-63. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Fillon G, Kahle PJ. Alpha-synuclein transgenic mice: relevance to multiple system atrophy. Mov Disord 2005; 20 Suppl 12: S64-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Furiya Y, Hirano M, Kurumatani N, Nakamuro T, Matsumura R, Futamura N, et al. Alpha-1-antichymotrypsin gene polymorphism and susceptibility to multiple system atrophy (MSA). Brain Res Mol Brain Res 2005; 138: 178-81. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Gazulla J, Benavente MI. [Improvements in the symptoms of olivopontocerebellar atrophy with gabapentin]. Rev Neurol 2005; 40: 285-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Geser F, Seppi K, Stampfer-Kountchev M, Kollensperger M, Diem A, Ndayisaba JP, et al. The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm 2005; 112: 1677-86. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Ghorayeb I, Bioulac B, Tison F. Sleep disorders in multiple system atrophy. J Neural Transm 2005; 112: 1669-75. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Ghorayeb I, Yekhlef F, Bioulac B, Tison F. Continuous positive airway pressure for sleep-related breathing disorders in multiple system atrophy: long-term acceptance. Sleep Med 2005; 6: 359-62. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Gilman S. Functional imaging with positron emission tomography in multiple system atrophy. J Neural Transm 2005; 112: 1647-55. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Gilman S, May SJ, Shults CW, Tanner CM, Kukull W, Lee VM, et al. The North American Multiple System Atrophy Study Group. J Neural Transm 2005; 112: 1687-94. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Hahn K, Ebersbach G. Sonographic assessment of urinary retention in multiple system atrophy and idiopathic Parkinson's disease. Mov Disord 2005; 20: 1499-502. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Healy DG, Abou-Sleiman PM, Quinn N, Ahmadi KR, Ozawa T, Kamm C, et al. UCHL-1 gene in multiple system atrophy: a haplotype tagging approach. Mov Disord 2005; 20: 1338-43. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Hemingway J, Franco K, Chmelik E. Shy-Drager syndrome: multisystem atrophy with comorbid depression. Psychosomatics 2005; 46: 73-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Higo R, Nito T, Tayama N. Swallowing function in patients with multiple-system atrophy with a clinical predominance of cerebellar symptoms (MSA-C). Eur Arch Otorhinolaryngol 2005; 262: 646-50. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Huang Y, Garrick R, Cook R, O'Sullivan D, Morris J, Halliday GM. Pallidal stimulation reduces treatment-induced dyskinesias in "minimal-change" multiple system atrophy. Mov Disord 2005; 20: 1042-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Infante J, Llorca J, Berciano J, Combarros O. Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factor-alpha gene polymorphisms and the risk for multiple system atrophy. J Neurol Sci 2005; 228: 11-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Iranzo A. Management of sleep-disordered breathing in multiple system atrophy. Sleep Med 2005; 6: 297-300. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Jamora RD, Gupta A, Tan AK, Tan LC. Clinical characteristics of patients with multiple system atrophy in Singapore. Ann Acad Med Singapore 2005; 34: 553-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Jellinger KA, Seppi K, Wenning GK. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 2005; 20 Suppl 12: S29-36. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Juh R, Pae CU, Lee CU, Yang D, Chung Y, Suh T, et al. Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping. Neurosci Res 2005; 52: 211-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Kamm C, Healy DG, Quinn NP, Wullner U, Moller JC, Schols L, et al. The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group. Brain 2005; 128: 1855-60. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 2005; 11: 381-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Klotz L, Klockgether T. Multiple system atrophy with macrosquare-wave jerks. Mov Disord 2005; 20: 253-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Kuriyama N, Mizuno T, Iida A, Watanabe Y, Nakagawa M. Autonomic nervous evaluation in the early stages of olivopontocerebellar atrophy. Auton Neurosci 2005; 123: 87-93. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Lee WH, Lee CC, Shyu WC, Chong PN, Lin SZ. Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3T. AJNR Am J Neuroradiol 2005; 26: 2238-42. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Leon-Sarmiento FE, Bayona-Prieto J, Gomez J. Neurophysiology of blepharospasm and multiple system atrophy: clues to its pathophysiology. Parkinsonism Relat Disord 2005; 11: 199-201; author reply 203-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Limberg N, Jeavons S, Robertson T, Boyle R. Pyramidal tract imaging in multiple-system atrophy. Mov Disord 2005; 20: 1527-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Mabuchi N, Hirayama M, Koike Y, Watanabe H, Ito H, Kobayashi R, et al. Progression and prognosis in pure autonomic failure (PAF): comparison with multiple system atrophy. J Neurol Neurosurg Psychiatry 2005; 76: 947-52. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Malone D, Dennis MS. Multiple system atrophy and hallucinations--a short report. Int J Geriatr Psychiatry 2005; 20: 699-700. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Mantoan L, Stefanova N, Egger KE, Jellinger KA, Poewe W, Wenning GK. Failure of caspase inhibition in the double-lesion rat model of striatonigral degeneration (multiple system atrophy). Acta Neuropathol 2005; 109: 191-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Matsui H, Udaka F, Miyoshi T, Hara N, Tamura A, Oda M, et al. Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features. Parkinsonism Relat Disord 2005; 11: 227-32. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Matsui H, Udaka F, Oda M, Kubori T, Nishinaka K, Kameyama M. Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy. Auton Neurosci 2005; 119: 56-60. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Miller DW, Johnson JM, Solano SM, Hollingsworth ZR, Standaert DG, Young AB. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm 2005; 112: 1613-24. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Nishimura M, Kuno S, Kaji R, Kawakami H. Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy. Mov Disord 2005; 20: 1031-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Nishimura M, Kuno S, Kaji R, Kawakami H. Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy. Neurosci Lett 2005; 374: 218-21. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Okuma Y, Fujishima K, Miwa H, Mori H, Mizuno Y. Myoclonic tremulous movements in multiple system atrophy are a form of cortical myoclonus. Mov Disord 2005; 20: 451-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Paviour DC, Williams D, Fowler CJ, Quinn NP, Lees AJ. Is sphincter electromyography a helpful investigation in the diagnosis of multiple system atrophy? A retrospective study with pathological diagnosis. Mov Disord 2005; 20: 1425-30. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Pellecchia MT, Pivonello R, Salvatore E, Faggiano A, Barone P, De Michele G, et al. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia. Clin Endocrinol (Oxf) 2005; 62: 428-33. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Pountney DL, Chegini F, Shen X, Blumbergs PC, Gai WP. SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy. Neurosci Lett 2005; 381: 74-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Pountney DL, Treweek TM, Chataway T, Huang Y, Chegini F, Blumbergs PC, et al. Alpha B-crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy. Neurotox Res 2005; 7: 77-85. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Puschban Z, Stefanova N, Petersen A, Winkler C, Brundin P, Poewe W, et al. Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophy. Brain Res Bull 2005; 68: 54-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Quinn NP. How to diagnose multiple system atrophy. Mov Disord 2005; 20 Suppl 12: S5-S10. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Saft C, Andrich J, Muller T, Przuntek H, Stucker M. [Segmental dysfunction of sweating in multiple system atrophy]. Hautarzt 2005; 56: 773-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Sakakibara R, Ito T, Yamamoto T, Uchiyama T, Liu Z, Hattori T. Vergence paresis in multiple system atrophy. Intern Med 2005; 44: 911-2. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Sakakibara R, Odaka T, Lui Z, Uchiyama T, Yamaguchi K, Yamaguchi T, et al. Dietary herb extract dai-kenchu-to ameliorates constipation in parkinsonian patients (Parkinson's disease and multiple system atrophy). Mov Disord 2005; 20: 261-2. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Sakamoto M, Uchihara T, Nakamura A, Mizutani T, Mizusawa H. Progressive accumulation of ubiquitin and disappearance of alpha-synuclein epitope in multiple system atrophy-associated glial cytoplasmic inclusions: triple fluorescence study combined with Gallyas-Braak method. Acta Neuropathol 2005; 110: 417-25. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Sasaki H. [Clinical studies on multiple system atrophy]. Nippon Naika Gakkai Zasshi 2005; 94: 1409-15. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Scherfler C, Sather T, Diguet E, Stefanova N, Puschban Z, Tison F, et al. Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy). J Neural Transm 2005; 112: 1025-33. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, Virgolini I, et al. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease. Brain 2005; 128: 1605-12. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Seppi K, Yekhlef F, Diem A, Luginger Wolf E, Mueller J, Tison F, et al. Progression of parkinsonism in multiple system atrophy. J Neurol 2005; 252: 91-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Serra-Ortega A, Torres A, Segreo M. [Spinal muscular atrophy associated with olivopontocerebellar hypoplasia. A case report]. Rev Neurol 2005; 40: 90-2. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Shaligram D, Gupte PL, Varghese M, Pandey RS. Electroconvulsive therapy in organic bipolar disorder with multiple system atrophy. J Ect 2005; 21: 254. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Shiga K, Yamada K, Yoshikawa K, Mizuno T, Nishimura T, Nakagawa M. Local tissue anisotropy decreases in cerebellopetal fibers and pyramidal tract in multiple system atrophy. J Neurol 2005; 252: 589-96. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Shigematsu K, Shono S, Hamada T, Higa K. [A patient with Shy-Drager syndrome managed under general anesthesia with thoracic epidural anesthesia]. Masui 2005; 54: 788-90. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Shults CW, Rockenstein E, Crews L, Adame A, Mante M, Larrea G, et al. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J Neurosci 2005; 25: 10689-99. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Skidmore F, Mikolenko I, Weiss H, Weiner W. Camptocormia in a patient with multiple system atrophy. Mov Disord 2005; 20: 1063-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy. Acta Neuropathol 2005; 110: 19-26. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Specht K, Minnerop M, Muller-Hubenthal J, Klockgether T. Voxel-based analysis of multiple-system atrophy of cerebellar type: complementary results by combining voxel-based morphometry and voxel-based relaxometry. Neuroimage 2005; 25: 287-93. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Srivastava T, Singh S, Goyal V, Shukla G, Behari M. "Hot cross bun" sign in two patients with multiple system atrophy-cerebellar. Neurology 2005; 64: 128. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, Kahle PJ, et al. Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol 2005; 166: 869-76. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Stefanova N, Reindl M, Poewe W, Wenning GK. In vitro models of multiple system atrophy. Mov Disord 2005; 20 Suppl 12: S53-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Stefanova N, Tison F, Reindl M, Poewe W, Wenning GK. Animal models of multiple system atrophy. Trends Neurosci 2005; 28: 501-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Suzuki A, Asahina M, Ishikawa C, Asahina KM, Honma K, Fukutake T, et al. Impaired circadian rhythm of gastric myoelectrical activity in patients with multiple system atrophy. Clin Auton Res 2005; 15: 368-72. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Swanson RL, Newberg AB, Acton PD, Siderowf A, Wintering N, Alavi A, et al. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease. Eur J Nucl Med Mol Imaging 2005; 32: 302-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Thomaides T, Karapanayiotides T, Zoukos Y, Haeropoulos C, Kerezoudi E, Demacopoulos N, et al. Gastric emptying after semi-solid food in multiple system atrophy and Parkinson disease. J Neurol 2005; 252: 1055-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Uchiyama T, Sakakibara R, Asahina M, Yamanishi T, Hattori T. Post-micturitional hypotension in patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 2005; 76: 186-90. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Uzawa A, Sakakibara R, Tamura N, Asahina M, Yamanaka Y, Uchiyama T, et al. Laryngeal abductor paralysis can be a solitary manifestation of multiple system atrophy. J Neurol Neurosurg Psychiatry 2005; 76: 1739-41. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Vanacore N. Epidemiological evidence on multiple system atrophy. J Neural Transm 2005; 112: 1605-12. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Vanacore N, Bonifati V, Fabbrini G, Colosimo C, De Michele G, Marconi R, et al. Case-control study of multiple system atrophy. Mov Disord 2005; 20: 158-63. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Vianello M, Manara R, Betterle C, Tavolato B, Mariniello B, Giometto B. X-linked adrenoleukodystrophy with olivopontocerebellar atrophy. Eur J Neurol 2005; 12: 912-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Wakabayashi K, Mori F, Nishie M, Oyama Y, Kurihara A, Yoshimoto M, et al. An autopsy case of early ("minimal change") olivopontocerebellar atrophy (multiple system atrophy-cerebellar). Acta Neuropathol 2005; 110: 185-90. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Wenning GK. Placebo-controlled trial of amantadine in multiple-system atrophy. Clin Neuropharmacol 2005; 28: 225-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Wenning GK, Geser F, Poewe W. Therapeutic strategies in multiple system atrophy. Mov Disord 2005; 20 Suppl 12: S67-76. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Wenning GK, Jellinger KA. The role of alpha-synuclein in the pathogenesis of multiple system atrophy. Acta Neuropathol 2005; 109: 129-40. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Yamamoto T, Sakakibara R, Uchiyama T, Liu Z, Ito T, Awa Y, et al. When is Onuf's nucleus involved in multiple system atrophy? A sphincter electromyography study. J Neurol Neurosurg Psychiatry 2005; 76: 1645-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Yamaoka Y. [Multiple system atrophy characterized by precentral atrophy and remarkable histological findings]. No To Shinkei 2005; 57: 255-65. www.ncbi.nlm.nih.gov/entrez/query.fcgi
Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, Uryu K, et al. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 2005; 45: 847-59. www.ncbi.nlm.nih.gov/entrez/query.fcgi